论文信息 - Phase II Study of Temozolomide (TMZ) and Everolimus (RAD001) Therapy for Metastatic Melanoma: A North Central Cancer Treatment Group Study, N0675 - 字舞流文

Phase II Study of Temozolomide (TMZ) and Everolimus (RAD001) Therapy for Metastatic Melanoma: A North Central Cancer Treatment Group Study, N0675

B. Pockaj | M. Thompson | S. Markovic | W. Maples | E. Creagan | W. Nevala | R. Dronca | T. Moore | J. Kaur | D. Perez | J. Allred | B. Marchello | E. A. Lieser